Johanna Friedl-Naderer
Chief Commercial Officer · 4 filings · Latest: Jun 16, 2026
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | Jun 16, 2026 | Sale | $18.33 | 145 | $2.7K | 154,208 | |
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | May 13, 2026 | Sale | $18.36 | 228 | $4.2K | 154,353 | |
DYN | Johanna Friedl-Naderer | Chief Commercial Officer | Mar 5, 2026 | Sale | $14.90 | 148 | $2.2K | 154,581 |